GLG News by Oncologists who Treat Hematologic Malignancies (US)
Request a free trial
March 14, 2008
FDA panel recommendations means less sales of ESA'a and negative implications for Amgen
Analysis of: FDA Panel Backs Anemia Drugs For Cancer Patients, but With Limits | online.wsj.com
Author: GLG Expert Contributor
Analysis of: FDA Panel Backs Anemia Drugs For Cancer Patients, but With Limits | online.wsj.com
Author: GLG Expert Contributor
An FDA panel recommended NOT to use ESA's for treatment of chemotherapy induced anemia in Breast cancer patients and head and neck acncer patients, a significant number of cancer patients. It also voted overwhelmingly to limit ESA's for non-curable cancer patients in the setting of palliative care....
March 11, 2008
A third world country balking at the cost of high priced cancer drugs their citizens can't afford? Go figure....
Analysis of: Thai Ministry to Recommend Ignoring Patents on Cancer Drugs | online.wsj.com
Author: GLG Expert Contributor
Analysis of: Thai Ministry to Recommend Ignoring Patents on Cancer Drugs | online.wsj.com
Author: GLG Expert Contributor
Manufacturers include Roche Holding AG and Novartis AG of Switzerland and Sanofi-Aventis. Generic versions of the antineoplastic agents will be made available and the patents obviously ignored.
March 11, 2008
Avastin: Not for every one with breast cancer, but benefit is real for selected patients.
Analysis of: The High Cost of a Cancer Drug | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: The High Cost of a Cancer Drug | www.nytimes.com
Author: GLG Expert Contributor
FDA's approval of Genentech's Avastin is backed both by efficacy data and aggressive political activism. Extension of PFS by almost 6 months and shrinking large tumors, thus improving quality of life, are tangible and real beneficial effects. Avastin was already being prescribed off-label. The approval...
March 10, 2008
Amgen and J & J: FDA adding insult to injury #5
Analysis of: FDA Adds More Black-Box Warnings To Anemia Drugs From Amgen, J&J | online.wsj.com
Author: GLG Expert Contributor
Analysis of: FDA Adds More Black-Box Warnings To Anemia Drugs From Amgen, J&J | online.wsj.com
Author: GLG Expert Contributor
The FDA is now warning of increased death & tumor growth in breast and cervical cancer patients.
March 10, 2008
Wouldn't you want 5 1/2 more months if you had metastatic breast cancer?
Analysis of: The High Cost of a Cancer Drug | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: The High Cost of a Cancer Drug | www.nytimes.com
Author: GLG Expert Contributor
This editorial is questioning the use of this expensive agent in patients with metastatic breast cancer when it only increases time to progression 5.5 months.
March 10, 2008
Teva's generic Irinotecan will gradually cut into the brand name use
Analysis of: Teva Announces Approval Of Generic Camptosar(R) | www.pipelinereview.com
Author: GLG Expert Contributor
Analysis of: Teva Announces Approval Of Generic Camptosar(R) | www.pipelinereview.com
Author: GLG Expert Contributor
Pfizer's Irinotecan ( CPT-11) is mostly used in colorectal cancer with some limited use in sarcomas, glioblastoma multiforme, and other solid tumors. Teva's generic compound is expected to be cheaper, and with current economic situation, may be mandated by third party payers to cut costs, and this will...
March 10, 2008
AS1409 : Not so novel drug in an already crowded market
Analysis of: Antisoma starts phase I clinical trial of AS1409 in renal cancer and melanoma | www.pipelinereview.com
Author: GLG Expert Contributor
Analysis of: Antisoma starts phase I clinical trial of AS1409 in renal cancer and melanoma | www.pipelinereview.com
Author: GLG Expert Contributor
Antisoma's AS 1409 has just entered a clinical phase I trial for patients with advanced melanoma and renal cancer. While efficacy results are years ago, this "immunotherapy" will be competing with many approved targeted agents in renal cancer ( Sutent, Nexavar, Torisel) and with many other immunotherapeutic...
March 7, 2008
American Cancer Society is promoting money in CaCa analysis?
Analysis of: Two Tests Added to Recommended List to Prevent or Detect Colorectal Cancer | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Two Tests Added to Recommended List to Prevent or Detect Colorectal Cancer | www.nytimes.com
Author: GLG Expert Contributor
Virtual Colonoscopy and stool analysis for DNA alterations for colon cancer, are being recommended for screening.
March 6, 2008
Heparin: Unfractionated Heparin, more expensive, less effective and dangerous compared to low molecular weight varieties
Analysis of: Acute Pulmonary Embolism | content.nejm.org
Author: GLG Expert Contributor
Analysis of: Acute Pulmonary Embolism | content.nejm.org
Author: GLG Expert Contributor
With recent developments in preparation of unfractionated heparins (http://www.nytimes.com/2008/03/06/health/06heparin.html?_r=1&ref=health&oref=slogin) not only are the LMWH varieties more effective as well as cheaper when all of the co factors are included, they...
March 5, 2008
Cholesterol lowering: to advertise or not???
Analysis of: Drug Pitchmen: Actor, Doctor or Pfizer’s Option | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Drug Pitchmen: Actor, Doctor or Pfizer’s Option | www.nytimes.com
Author: GLG Expert Contributor
"Celebrity" advertisements of percription drugs are disingenuous?
Previous Page : 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Next161 to 170 of 702
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Why the doctor can't see you now
seattlepi.nwsource.com
Johnson & Johnson buys medical device maker
www.nytimes.com
Potassium loss from blood pressure drugs may explain higher risk of adult diabetes
www.fiercebiotech.com
McKesson Agrees To Settlement In Pricing Suits
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

